Zobrazeno 1 - 10
of 270
pro vyhledávání: '"C, Bonifati"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9921245f626c55154a844d63497cf7af
https://doi.org/10.1111/jdv.18255
https://doi.org/10.1111/jdv.18255
Autor:
E. Berardesca, C. Bonifati
Publikováno v:
Reumatismo, Vol 59, Iss 1s, Pp 64-67 (2011)
Several tools have been introduced in clinical trials to quantify the severity and the response to a given therapeutic regimen of both psoriasis and psoriatic arthritis. Each method present specific advantages and limitations. Here we will discuss so
Externí odkaz:
https://doaj.org/article/18d8eb693dfb4be58547d73f8cc26134
Autor:
A. Cristaudo, D. Graceffa, F. Pimpinelli, F. Sperati, G. Spoletini, C. Bonifati, R. Pellini, V. Lora, M. Pontone, O. Di Bella, D. Bracco, A. Morrone
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce20b6f6943af366ec7538f260a922bf
https://doi.org/10.1111/jdv.17861
https://doi.org/10.1111/jdv.17861
Autor:
P. Cordiali-Fei, L. Bianchi, C. Bonifati, E. Trento, M. Ruzzetti, F. Francesconi, S. Bultrini, G. D’Agosto, V. Bordignon, V. Francavilla, A. Tripiciano, A. Chiricozzi, E. Campione, C. Cavallotti, A. Orlandi, E. Berardesca, A. Di Carlo, S. Chimenti, F. Ensoli
Publikováno v:
Mediators of Inflammation, Vol 2014 (2014)
Externí odkaz:
https://doaj.org/article/5e210bbb59e54840af68fb90e1d06eb2
Publikováno v:
Kidney International Reports. 7:S455
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68435537a09ae1caefac1374c9744b64
https://doi.org/10.1016/j.ekir.2022.04.061
https://doi.org/10.1016/j.ekir.2022.04.061
Autor:
M. S. Chimenti, M. Galluzzo, M. Talamonti, A. Campanati, C. Bonifati, P. Bruni, G. Caldarola, A. Carpentieri, A. Chiricozzi, C. De Simone, F. Diotallevi, M. Esposito, C. Fiorella, D. Graceffa, F. Loconsole, K. Hansel, C. Mugheddu, M. Papini, A. Richetta, A. Bergamini, M. M. Luchetti, L. Atzori, K. Peris, A. Offidani, L. Stingeni, L. Bianchi
Publikováno v:
Annals of the Rheumatic Diseases. 81:1587.1-1587
BackgroundPsoriasis (PSO) is a systemic immune-mediated disorder, characterized by inflammation skin and joint manifestations: it is known that up to 30% of PsO patients develop PsA.PsO and PsA share common etiopathogenetic pathways, as IL-23/IL-17 a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4b1ce629e8467aae9009645052cb832
https://doi.org/10.1136/annrheumdis-2022-eular.4327
https://doi.org/10.1136/annrheumdis-2022-eular.4327
Autor:
M Talamonti, G Malara, Y Natalini, F Bardazzi, A Conti, A Chiricozzi, C Mugheddu, P Gisondi, S Piaserico, G Pagnanelli, P Amerio, C Potenza, F Cantoresi, M Fargnoli, A Balato, F Loconsole, A Offidani, C Bonifati, F Prignano, M Bartezaghi, A Rausa, E Aloisi, R Orsenigo, A Costanzo, f Group
Publikováno v:
Acta Dermato-Venereologica, Vol 101, Iss 3, p adv00422 (2021)
This study evaluated whether secukinumab treatment for patients with moderate to severe plaque psoriasis correlates with improvements in symptoms of anxiety and depression. SUPREME was a 24-week, phase IIIb, multicentre, prospective study conducted a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f8209c302db1665ab4ccaf7b88c0e49
http://hdl.handle.net/11577/3381136
http://hdl.handle.net/11577/3381136
Publikováno v:
Case Reports in Rheumatology, Vol 2012 (2012)
Bevacizumab is a recombinant humanised monoclonal antibody directed against the vascular endothelial growth factor (VEGF). The drug, alone or in combination with other anticancer agents, has been shown to be effective against several types of neoplas
Externí odkaz:
https://doaj.org/article/d2aef52c0ab641e1b988f93edb6422ce
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.